AAAAAA

   
Results: 1-12 |
Results: 12
AXONAL TRANSECTION IN THE LESIONS OF MULTIPLE-SCLEROSIS
Authors: TRAPP BD PETERSON J RANSOHOFF RM RUDICK R MORK S BO L
Citation: Bd. Trapp et al., AXONAL TRANSECTION IN THE LESIONS OF MULTIPLE-SCLEROSIS, The New England journal of medicine, 338(5), 1998, pp. 278-285
NEUROPSYCHOLOGICAL EFFECTS OF AVONEX(R) (INTERFERON-BETA-1A) IN RELAPSING MULTIPLE-SCLEROSIS (MS)
Authors: FISCHER JS PRIORE R JACOBS L COOKFAIR D RUDICK R HERNDON R RICHERT J SALAZAR A GOODKIN D GRANGER C SIMON J GRAFMAN J LEZAK M OREILLY K SCHACTER M SHUCARD D DAVIDSON A WENDE K
Citation: Js. Fischer et al., NEUROPSYCHOLOGICAL EFFECTS OF AVONEX(R) (INTERFERON-BETA-1A) IN RELAPSING MULTIPLE-SCLEROSIS (MS), Neurology, 50(4), 1998, pp. 1070-1070
PRIMARY CHRONIC PROGRESSIVE MYELOPATHY - DISEASE FEATURES AND RELATIONSHIP TO MS
Authors: RENSEL MR WEINSTOCKGUTTMAN B RUDICK R
Citation: Mr. Rensel et al., PRIMARY CHRONIC PROGRESSIVE MYELOPATHY - DISEASE FEATURES AND RELATIONSHIP TO MS, Neurology, 50(4), 1998, pp. 4032-4032
CSF KAPPA-LIGHT-CHAINS AND GADOLINIUM-ENHANCING BRAIN-LESIONS AS PREDICTORS OF RESPONSE TO THERAPY WITH INTERFERON-BETA 1A (AVONEX(R)) IN PATIENTS WITH RELAPSING MULTIPLE-SCLEROSIS
Authors: RUDICK R COOKFAIR D SIMON J SIMONIAN N JACOBS L HERNDON R RICHERT J SALAZAR A FISCHER J GRANGER C GOODKIN D OREILLY K BOYLE S
Citation: R. Rudick et al., CSF KAPPA-LIGHT-CHAINS AND GADOLINIUM-ENHANCING BRAIN-LESIONS AS PREDICTORS OF RESPONSE TO THERAPY WITH INTERFERON-BETA 1A (AVONEX(R)) IN PATIENTS WITH RELAPSING MULTIPLE-SCLEROSIS, Neurology, 50(4), 1998, pp. 47001-47001
RECOMMENDATIONS FROM THE NATIONAL MULTIPLE-SCLEROSIS SOCIETY CLINICALOUTCOMES ASSESSMENT TASK-FORCE
Authors: RUDICK R ANTEL J CONFAVREUX C CUTTER G ELLISON G FISCHER J LUBLIN F MILLER A PETKAU J RAO S REINGOLD S SYNDULKO K THOMPSON A WALLENBERG J WEINSHENKER B WILLOUGHBY E
Citation: R. Rudick et al., RECOMMENDATIONS FROM THE NATIONAL MULTIPLE-SCLEROSIS SOCIETY CLINICALOUTCOMES ASSESSMENT TASK-FORCE, Annals of neurology, 42(3), 1997, pp. 379-382
FATIGUE SEVERITY IN LOW DISABILITY MS PATIENTS PARTICIPATING IN A PHASE-III TRIAL OF AVONEX(TM) (IFN-BETA-1A) FOR RELAPSING MULTIPLE-SCLEROSIS
Authors: COOKFAIR DL FISCHER J RUDICK R JACOBS L HERNDON R RICHERT J SALAZAR A GRANGER C SIMON J GOODKIN D
Citation: Dl. Cookfair et al., FATIGUE SEVERITY IN LOW DISABILITY MS PATIENTS PARTICIPATING IN A PHASE-III TRIAL OF AVONEX(TM) (IFN-BETA-1A) FOR RELAPSING MULTIPLE-SCLEROSIS, Neurology, 48(3), 1997, pp. 3066-3066
QUALITY-OF-LIFE IN LOW-DISABILITY MULTIPLE-SCLEROSIS PATIENTS PARTICIPATING IN A PHASE-III TRIAL OF INTERFERON BETA-1A FOR RELAPSING MULTIPLE-SCLEROSIS
Authors: COOKFAIR DL FISCHER J RUDICK R BOURDETTE D OREILLY K JACOBS L HERNDON R RICHERT J SALAZAR A GRANGER C SIMON J GOODKIN D
Citation: Dl. Cookfair et al., QUALITY-OF-LIFE IN LOW-DISABILITY MULTIPLE-SCLEROSIS PATIENTS PARTICIPATING IN A PHASE-III TRIAL OF INTERFERON BETA-1A FOR RELAPSING MULTIPLE-SCLEROSIS, Annals of neurology, 40(3), 1996, pp. 234-234
GUIDELINES TO AVOID ERRORS IN THE DIAGNOSIS OF MULTIPLE-SCLEROSIS
Authors: KATZAN I RUDICK R
Citation: I. Katzan et R. Rudick, GUIDELINES TO AVOID ERRORS IN THE DIAGNOSIS OF MULTIPLE-SCLEROSIS, Annals of neurology, 40(3), 1996, pp. 246-246
CLINICAL OUTCOMES ASSESSMENT IN MULTIPLE-SCLEROSIS
Authors: RUDICK R ANTEL J CONFAVREUX C CUTTER G ELLISON G FISCHER J LUBLIN F MILLER A PETKAU J RAO S REINGOLD S SYNDULKO K THOMPSON A WALLENBERG J WEINSHENKER B WILLOUGHBY E
Citation: R. Rudick et al., CLINICAL OUTCOMES ASSESSMENT IN MULTIPLE-SCLEROSIS, Annals of neurology, 40(3), 1996, pp. 469-479
THE NATURAL-HISTORY OF MS BASED ON AN ANNUAL MR SNAPSHOT - RESULTS FROM THE MSCRG STUDY OF INTRAMUSCULAR RECOMBINANT INTERFERON-BETA-1A
Authors: SIMON JH JACOBS L COOKFAIR D RUDICK R HERNDON R SALAZAR A RICHERT J CHOI K FISCHER J GOODKIN D GRANGER C
Citation: Jh. Simon et al., THE NATURAL-HISTORY OF MS BASED ON AN ANNUAL MR SNAPSHOT - RESULTS FROM THE MSCRG STUDY OF INTRAMUSCULAR RECOMBINANT INTERFERON-BETA-1A, Neurology, 45(4), 1995, pp. 418-418
RESULTS OF A PHASE-III TRIAL OF INTRAMUSCULAR RECOMBINANT BETA-INTERFERON AS TREATMENT FOR MULTIPLE-SCLEROSIS
Authors: JACOBS L COOKFAIR D RUDICK R HERNDON R RICHERT J SALAZAR A FISCHER J GRANGER C SIMON J GOODKIN D
Citation: L. Jacobs et al., RESULTS OF A PHASE-III TRIAL OF INTRAMUSCULAR RECOMBINANT BETA-INTERFERON AS TREATMENT FOR MULTIPLE-SCLEROSIS, Annals of neurology, 36(2), 1994, pp. 259-259
A PHASE-III TRIAL OF INTRAMUSCULAR RECOMBINANT INTERFERON-BETA AS TREATMENT FOR MULTIPLE-SCLEROSIS - CURRENT STATUS
Authors: JACOBS L COOKFAIR D RUDICK R HERNDON R SALAZAR A RICHERT J FISCHER J GOODKIN D GRANGER C SIMON J EMRICH L
Citation: L. Jacobs et al., A PHASE-III TRIAL OF INTRAMUSCULAR RECOMBINANT INTERFERON-BETA AS TREATMENT FOR MULTIPLE-SCLEROSIS - CURRENT STATUS, Annals of neurology, 34(2), 1993, pp. 310-310
Risultati: 1-12 |